Cornea | Ophthalmology Innovation Source

Panoptes Pharma

Franz Obermayr gives a short overview of Panoptes Pharma founded only last year, covering only one of their developments: C0C01 for local treatment in ophthalmology. Presenter: Franz Obermayr, PhD Dr. Franz Obermayr is Co-Founder and serves as CEO of Panoptes. Before that he was Head of Clinical Development at Nabriva, where he led the clinical efforts…

Anew Optics

Anna Hayes describes Anew Optics lens design program with the specific objective of removing or managing significantly post-cataract surgery patient health issues including instability of refractive correction, capsular opacification & posterior segment events. Presenter: Anna Hayes Anna S. Hayes, CEO founded Anew Optics, Inc. and has guided the Company since its inception, managing the full…

Industry Perspectives on Ophthalmic Opportunities

Gain insight on how industry thinks about a dry eye opportunity, or a cross-linking opportunity, or a uveitis opportunity. The discussion is about no so much what they liked and didn’t like about the earlier presentations at OIS@ASCRS, but in general, what does a company have to do to get their attention, take a deeper…

Avedro

Presenter: David Muller, PhD Dr. Muller recognized the potential of using advanced methods to gently reshape the cornea and in 2007 founded Avedro, Inc., where he serves as the CEO. View Full Profile

CXLO

Presenter: Roy Rubinfeld, MD Dr. Rubinfeld was the first Washington area ophthalmologist to become involved in the care of laser vision correction patients in 1991. He has performed tens of thousands of LASIK and many PRK and other vision correction procedures. View Full Profile

Cross Linking Market Overview

Presenter: Stephen Slade, MD Stephen Glenn Slade graduated from the University of Texas (Summa Cum Laude, Phi Beta Kappa) with a final, elective year spent at Guy’s Hospital in London. He completed a residency at LSU in New Orleans and fellowships at Baylor College of Medicine and Project ORBIS in New York. View Full Profile

Mimetogen

Presenter: Garth Cumberlidge Garth Cumberlidge has served as the Company’s President, CEO and member of the Board of Directors since September 2005. Dr. Cumberlidge has over 25 years’ experience in the research products, diagnostics and healthcare industries. View Full Profile

RPS

Presenter: Robert P. Sambursky, MD Robert Sambursky, MD is CEO, and President of RPS Diagnostics (RPS®), an innovative biotechnology company with a proprietary point-of-care diagnostic testing platform to rapidly and accurately diagnose a variety of infectious diseases and inflammatory conditions. View Full Profile

TearScience

Presenter: Tim Willis Mr. Willis has more than 35 years of medical device industry experience. Tim is an entrepreneur and inventor and has been responsible for the development and launch of 50+ products that today represent over a half billion dollars in annual sales. View Full Profile

TearLab

Presenter: Elias Vamvakas Mr Vamvakas is the Chairman and CEO of TearLab Corporation. Prior to TearLab, Mr. Vamvakas co-founded TLCVision (NASDAQ/TLCV, TSX/TLC) in 1993 where he served as President and CEO until 2003. View Full Profile

Dry Eye Market Overview

Edward J Holland, MD explains where we are and where we might be going with Dry Eye, stressing the significance of the Dry Eye problem and the opportunity it presents to the industry. Presenter: Edward Holland, MD Dr. Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Clinical Ophthalmology at…

NexisVision Pivots to Develop a Novel Contact Lens Technology

Formed in 2008 NexisVision’s initial target was next generation corneal refractive surgery or in other words, the comfort and function of LASIK without a flap. In the last 18-24 months the company has pivoted to develop a novel contact lens technology. Presenter: Marguerite McDonald, MD Marguerite McDonald, MD, FACS, is a board-certified ophthalmologist offering corneal,…